Built an AI-native operating system for drug discovery on Google Cloud, using deep learning to speed development and success rate of new treatments.
Built an AI-native operating system for drug discovery on Google Cloud, using deep learning to speed development and success rate of new treatments.
Google supplies AI to pharma through several distinct lines — Gemini/Vertex AI as an enterprise platform, and AlphaFold-based drug design licensed commercially through Isomorphic Labs.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Google on its own site — read the original case study on cloud.google.com ↗
Note: Fetch tool truncated the page before reaching the article body on repeated attempts (only a generic placeholder title, 'Recursion case study | Google Cloud', was returned each time); unable to verify a real title or extract genuine summary content.
Related use cases
- 01XtalPi: Accelerating drug discovery and development to offer more timely and affordable medical treatments
- 02AI-based computational disease models on Google Cloud to help pharma shorten clinical trials and cut drug-development costs.
- 03Oncology biotech uses Google Cloud to scale molecular dynamics simulations, cutting simulation time from weeks to overnight and false positives by 50%.
- 04Cradle: Revolutionizing Protein Engineering with a secure AI platform built on Google Cloud
- 05AI-driven drug discovery company; moved to GKE for flexible, scalable protein-structure processing (millions of structures).
- 06Allcyte: Breaking new ground in cancer precision medicine with AI and Google Cloud